A study by Clifford W. Colwell Jr., MD, Mark I. Froimson, MD, Scott D. Anseth, MD, Nicholas J. Giori, MD, PhD, William G. Hamilton, MD, Robert L. Barrack, MD, Knute C. Buehler, MD, Michael A. Mont, MD, Douglas E. Padgett, MD, Pamela A. Pulido, BSN, and C. Lowery Barnes, MD
Abstract
Venous thromboembolic events, either deep venous thrombosis or pulmonary embolism, are important com- plications in patients undergoing knee or hip arthroplasty. The purpose of this study was to evaluate the effectiveness of a mobile compression device (ActiveCare1S.F.T.) with or without aspirin compared with current pharmacological protocols for prophylaxis against venous thromboembolism in patients undergoing elective primary unilateral arthroplasty of a lower-extremity joint.
Results
Venous thromboembolic events, either deep venous thrombosis or pulmonary embolism, are important com- plications in patients undergoing knee or hip arthroplasty. The purpose of this study was to evaluate the effectiveness of a mobile compression device (ActiveCare1S.F.T.) with or without aspirin compared with current pharmacological protocols for prophylaxis against venous thromboembolism in patients undergoing elective primary unilateral arthroplasty of a lower-extremity joint.
This study was published in The Journal of Bone and Joint Surgery.